Retirement Systems of Alabama Lowers Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Retirement Systems of Alabama trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 2.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 15,523 shares of the biotechnology company’s stock after selling 366 shares during the period. Retirement Systems of Alabama’s holdings in Axon Enterprise were worth $4,010,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. HB Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 3.9% during the fourth quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock valued at $294,000 after purchasing an additional 43 shares during the last quarter. UMB Bank n.a. raised its holdings in Axon Enterprise by 11.0% in the 4th quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock worth $115,000 after acquiring an additional 44 shares during the last quarter. Lindbrook Capital LLC raised its holdings in Axon Enterprise by 43.3% in the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after acquiring an additional 52 shares during the last quarter. Greenleaf Trust raised its holdings in Axon Enterprise by 3.6% in the 3rd quarter. Greenleaf Trust now owns 1,540 shares of the biotechnology company’s stock worth $306,000 after acquiring an additional 54 shares during the last quarter. Finally, Czech National Bank raised its holdings in Axon Enterprise by 0.4% in the 4th quarter. Czech National Bank now owns 12,336 shares of the biotechnology company’s stock worth $3,187,000 after acquiring an additional 54 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 2.9 %

AXON opened at $327.64 on Tuesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. Axon Enterprise, Inc. has a fifty-two week low of $175.37 and a fifty-two week high of $329.87. The firm’s fifty day moving average is $309.95 and its 200 day moving average is $266.41. The stock has a market cap of $24.72 billion, a price-to-earnings ratio of 142.45 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Monday, May 6th. The biotechnology company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The company had revenue of $460.74 million for the quarter, compared to analysts’ expectations of $441.57 million. During the same quarter in the previous year, the company earned $0.51 EPS. Axon Enterprise’s revenue for the quarter was up 34.3% on a year-over-year basis. On average, sell-side analysts forecast that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on AXON shares. William Blair restated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. Needham & Company LLC reaffirmed a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a research report on Wednesday, April 24th. Argus assumed coverage on shares of Axon Enterprise in a research report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 target price for the company. Robert W. Baird lifted their target price on shares of Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research report on Thursday, February 22nd. Finally, Barclays lifted their target price on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research report on Thursday, February 29th. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $323.09.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.